--:--:--ET

live

S&P 5007,500.58+1.08%

NASDAQ30,406.19+2.48%

DOW51,564.7+0.14%

VIX16.78+2.32%

US10Y4.45-0.27%

EUR/USD1.1506-0.93%

GOLD4,300.5-1.26%

WTI75.22-0.90%

BTC64,442.01-1.87%

S&P 5007,500.58+1.08%

NASDAQ30,406.19+2.48%

DOW51,564.7+0.14%

VIX16.78+2.32%

US10Y4.45-0.27%

EUR/USD1.1506-0.93%

GOLD4,300.5-1.26%

WTI75.22-0.90%

BTC64,442.01-1.87%

4528.T

Ono Pharmaceutical Co., Ltd.

HealthcareDrug Manufacturers - GeneralJPJPYPeers →Country macro →

$2,249.00

+1.76%Jun 19, 2026

Market cap

$1.1T

52w range

—

P / E

—

EPS · FY 2026

$148.42

Volume

—

Revenue · FY 2026

$515.79B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Financials Enterprise value Ratios Multiples Segments Profile Management

Explain this page

Arphra AIPlain-English read on Ono Pharmaceutical Co., Ltd.’s valuation

Revenue · 5Y

$515.78B

FY26

Net income · 5Y

$69.77B

FY26

Margins · FY2026

Gross margin72.5%

Operating margin20.0%

Net margin13.5%

FCF margin25.4%

income_statement_annual

Line item	FY2026	YoY
Revenue	515.78B	—
Gross profit	374.07B	—
R&D	147.04B	—
Operating income	103.33B	—
Net income	69.77B	—
Diluted EPS	148.42	—
Net margin	13.5%	—

Pro

Financials

Full income statement, balance sheet, and cash-flow history is included with Pro.